Discontinued — last reported Q4 '20
Current Assets
Available-for-Sale Debt Securities - Amortized Cost
Gilead Sciences Available-for-Sale Debt Securities - Amortized Cost decreased by 75.9% to $19.00M in Q3 2025 compared to the prior quarter. Over 4 years (FY 2020 to FY 2024), Available-for-Sale Debt Securities - Amortized Cost shows a downward trend with a -100.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2020
How to read this metric
An increase reflects new debt security purchases, while a decrease indicates maturities or sales of existing holdings.
Detailed definition
This represents the original cost of debt securities classified as available-for-sale, adjusted for amortization of prem...
Peer comparison
Standard accounting metric; allows for comparison of investment cost bases across financial institutions.
Metric ID:
afs_debt_securities_amortized_costHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.39B | $2.50B | $1.09B | $962.00M | $1.02B | $2.33B | $1.01B | $1.01B | $1.23B | $2.43B | $0.00 | $79.00M | $19.00M |
| QoQ Change | — | -17.6% | +79.9% | -56.4% | -11.8% | +5.8% | +128.4% | -56.7% | +0.8% | +21.6% | +97.1% | -100.0% | — | -75.9% |
| YoY Change | — | — | — | — | -43.0% | -26.8% | -7.0% | -7.8% | +5.4% | +21.1% | +4.5% | -100.0% | — | — |
Range$0.00 – $2.50B
CAGR-74.9%
Avg YoY Growth-19.2%
Median YoY Growth-7.4%
Available-for-Sale Debt Securities - Amortized Cost at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's available-for-sale debt securities - amortized cost?
- Gilead Sciences (GILD) reported available-for-sale debt securities - amortized cost of $19.00M in Q3 2025.
- What is the long-term trend for Gilead Sciences's available-for-sale debt securities - amortized cost?
- Over 4 years (2020 to 2024), Gilead Sciences's available-for-sale debt securities - amortized cost has grown at a -100.0% compound annual growth rate (CAGR), from $2.02B to $0.00.
- What does available-for-sale debt securities - amortized cost mean?
- The original purchase price of debt investments, adjusted for accounting adjustments, excluding current market price changes.